H. Evans

Phase II trial of oral altretamine for relapsed ovarian carcinoma: evaluation of defining response by serum CA125.

G. Rustin, W. Oster, J. Ledermann, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Loss of chromosome 10 is an independent prognostic factor in high-grade gliomas

C. Brock, M. Bower, J. Clark, 1999, British Journal of Cancer.

The Charing Cross Hospital experience with temozolomide in patients with gliomas.

E. Newlands, C. Brock, M. Bower, 1996, European journal of cancer.

Phase I trial of temozolomide using an extended continuous oral schedule.

M. Roddie, G. Rustin, E. Newlands, 1998, Cancer research.

Early evaluation of tumour metabolic response using [18F]fluorodeoxyglucose and positron emission tomography:a pilot study following the phase II chemotherapy schedule for temozolomide in recurrent high-grade gliomas

H Evans, E S Newlands, P. Price, 2000, British Journal of Cancer.

FaFEC: a novel regimen for advanced ovarian cancer.

G. Rustin, M. Bower, K. Goodchild, 1997, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

A phase II trial of cabazitaxel as second line chemotherapy in relapsed locally advanced and/or metastatic carcinoma of the penis

L. Pickering, T. Elliott, A. Mitra, 2019, The Journal of international medical research.